Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1991
Human lymphokine-activated killer cells augment immunotherapy of human colon carcinoma xenografts with monoclonal antibody D612T K Pendurthi, J Schlom, F J PrimusSurgical Endoscopy|February 1, 1995
Laparoscopic bilateral inguinal hernia repair under local anesthesiaT K Pendurthi, E J DeMaria, J M KellumOncology (Williston Park, N.Y.)|September 1, 1996
Surgical management of pancreatic cancerJ P Hoffman, D E Johnson, T K PendurthiInternational Journal of Cancer|December 15, 1990
Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612T K Pendurthi, R Parker, J Schlom, et al.Hepato-Gastroenterology|July 31, 1998
Preoperative radiation therapy and chemotherapy for adenocarcinoma of the pancreasJ P Hoffman, T K Pendurthi, E Ross, et al.Journal of Hepato-Biliary-Pancreatic Surgery|January 9, 1999
Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of VaterJ P Hoffman, H S Cooper, N A Young, et al.Brain, Behavior and Evolution|January 1, 1986
Immunocytochemical localization and immunological characterization of vitamin D-dependent calcium-binding protein in the bullfrog cerebellumA G Gona, T K Pendurthi, S Al-Rabiai, et al.The American Surgeon|July 9, 1998
Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinomaT K Pendurthi, J P Hoffman, E Ross, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cellsF J Primus, T K Pendurthi, P Hutzell, et al.The American Surgeon|August 1, 1997
Implications of fine-needle aspiration in patients with resectable pancreatic cancerD E Johnson, T K Pendurthi, A M Balshem, et al.Pageof 1